Search results
Petri Dish: NIH sends BioNTech notice of default; Intellia ends Regeneron deal - Boston Business...
The Business Journals· 12 hours agoIn today’s Petri Dish we’ll cover why Replimune Group is shaking up its C-suite, how BioNTech is...
BioNTech gets US agency notice over default on COVID vaccine royalties
Reuters via AOL· 4 days agoBioNTech, which partnered with U.S. pharma giant Pfizer for its COVID-19 vaccine, however, said it...
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
Simply Wall St. via Yahoo Finance· 6 days agoBioNTech SE (NASDAQ:BNTX) just released its latest annual report and things are not looking great. ...
BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of “Hold” from Analysts
ETF DAILY NEWS· 2 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) has received an average recommendation of “Hold” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings ...
Analysts Set BioNTech SE (NASDAQ:BNTX) Price Target at $142.43
ETF DAILY NEWS· 4 days agoShares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given a consensus rating of “Hold” by the twelve analysts that are presently covering the company, Marketbeat ...
BioNTech SE (NASDAQ:BNTX) Position Raised by Exchange Traded Concepts LLC
ETF DAILY NEWS· 6 days agoExchange Traded Concepts LLC increased its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 33.9% during the 4th quarter, according to the company in its most ...
BioNTech (NASDAQ:BNTX) Price Target Cut to $90.00
ETF DAILY NEWS· 5 days agoBioNTech (NASDAQ:BNTX – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from $99.00 to $90.00 in a research report issued to clients and ...
BioNTech Full Year 2023 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 4 days agoBioNTech (NASDAQ:BNTX) Full Year 2023 Results Key Financial Results Revenue: €3.82b (down 78% from...
NIH sends BioNTech 'notice of default' over Covid vaccine royalties
Endpoints News· 3 days agoBioNTech disclosed on Monday that it received a “notice of default” from the NIH over alleged...
HSBC cuts BioNTech stock target to $90, maintains hold rating By Investing.com
Investing.com· 6 days agoOn Friday, HSBC adjusted its stance on BioNTech (NASDAQ:BNTX) shares, reducing the price target to...